glp-1 itching Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports - JDDonline Itchy Skin on Ozempic: Causes

Explore second-phase GLP-1 study insights on improved medical cost growth, adherence and womens health.

Through differentiated development strategies and novel mechanisms that address unmet needs in obesity treatment, Hanmi is committed to becoming a global leader in obesity innovation

Currently, there are more than 1 billion people worldwide with obesity, many of whom also have type 2 diabetes mellitus or prediabetes

For GLP-1 users, those outcomes are not theoretical, they map directly onto daily challenges around energy dips, under-eating and nutritional adequacy.

This innovation addresses a long-standing barrier in obesity care: the reliance on injectable therapies